Cited by 140Protein Hydrolysis and Bioactive PeptidesSeaweed-derived Bioactive CompoundsPeptidase Inhibition and Analysis

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Preparation and Identification of ACE Inhibitory Peptides from the Marine Macroalga Ulva intestinalis

Open access

Abstract

Angiotensin I-converting enzyme (ACE) inhibitory peptides derived from seaweed represent a potential source of new antihypertensive. The aim of this study was to isolate and purify ACE inhibitory peptides (ACEIPs) from the protein hydrolysate of the marine macroalga Ulva intestinalis. U. intestinalis protein was hydrolyzed by five different proteases (trypsin, pepsin, papain, α-chymotrypsin, alcalase) to prepare peptides; compared with other hydrolysates, the trypsin hydrolysates exhibited the highest ACE inhibitory activity. The hydrolysis conditions were further optimized by response surface methodology (RSM), and the optimum conditions were as follows: pH 8.4, temperature 28.5 °C, enzyme/protein ratio (E/S) 4.0%, substrate concentration 15 mg/mL, and enzymolysis time 5.0 h. After fractionation and purification by ultrafiltration, gel exclusion chromatography and reverse-phase high-performance liquid chromatography, two novel purified ACE inhibitors with IC50 values of 219.35 μM (0.183 mg/mL) and 236.85 μM (0.179 mg/mL) were obtained. The molecular mass and amino acid sequence of the ACE inhibitory peptides were identified as Phe-Gly-Met-Pro-Leu-Asp-Arg (FGMPLDR; MW 834.41 Da) and Met-Glu-Leu-Val-Leu-Arg (MELVLR; MW 759.43 Da) by ultra-performance liquid chromatography-tandem mass spectrometry. A molecular docking study revealed that the ACE inhibitory activities of the peptides were mainly attributable to the hydrogen bond and Zn(II) interactions between the peptides and ACE. The results of this study provide a theoretical basis for the high-valued application of U. intestinalis and the development of food-derived ACE inhibitory peptides.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/md17030179

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Angiotensin I-converting enzyme (ACE) inhibitory activities of U. intestinalis protein hydrolysates produced by different enzymes. Each point is the mean of three determinations (n = 3) ± SD. Different letters indicate significant differences. The concentration of each hydrolysate was 2.5 mg/mL; crude protein (2.5 mg/mL) was used as the positive control.
Figure 1 Angiotensin I-converting enzyme (ACE) inhibitory activities of U. intestinalis protein hydrolysates produced by different enzymes. Each point is the mean of three determinations (n = 3) ± SD. Different letters indicate significant differences. The concentration of each hydrolysate was 2.5 mg/mL; crude protein (2.5 mg/mL) was used as the positive control.CC BY · PubMed Central
Figure 2 Effects of hydrolysis pH (A), temperature (B), substrate concentration (C), E/S ratio (D), and reaction time (E) on ACE inhibitory activity of protein hydrolysates from U. intestinalis.
Figure 2 Effects of hydrolysis pH (A), temperature (B), substrate concentration (C), E/S ratio (D), and reaction time (E) on ACE inhibitory activity of protein hydrolysates from U. intestinalis.CC BY · PubMed Central
Figure 3 Contour plots and response surface plots for pH (A), temperature (B), and substrate concentration (C) to ACE inhibition rate.
Figure 3 Contour plots and response surface plots for pH (A), temperature (B), and substrate concentration (C) to ACE inhibition rate.CC BY · PubMed Central
Figure 4 Sephadex G-25 gel filtration chromatogram of <3 kDa fraction of trypsin hydrolysate from U. intestinalis. (A) The fraction was divided into five parts (A–E) by Sephadex G-25. (B) The ACE inhibitory activity (1.5 mg/mL) and percentage of A–E. (C) The fraction was divided into three parts (C1–C3) by Sephadex G-15. (D) The ACE inhibitory activity (1.5 mg/mL) and percentage of C1 to C3.
Figure 4 Sephadex G-25 gel filtration chromatogram of <3 kDa fraction of trypsin hydrolysate from U. intestinalis. (A) The fraction was divided into five parts (A–E) by Sephadex G-25. (B) The ACE inhibitory activity (1.5 mg/mL) and percentage of A–E. (C) The fraction was divided into three parts (C1–C3) by Sephadex G-15. (D) The ACE inhibitory activity (1.5 mg/mL) and percentage of C1 to C3.CC BY · PubMed Central
Figure 5 ACE inhibitory activity of fraction C2 from RP-HPLC. (A) The fraction was divided into 9 parts (C2-1 to C2-9) by RP-HPLC. (B) ACE inhibitory activity (1.5 mg/mL) and percentages of C2-1 to C2-9. Means with different lower case letters are significantly different (p < 0.05).
Figure 5 ACE inhibitory activity of fraction C2 from RP-HPLC. (A) The fraction was divided into 9 parts (C2-1 to C2-9) by RP-HPLC. (B) ACE inhibitory activity (1.5 mg/mL) and percentages of C2-1 to C2-9. Means with different lower case letters are significantly different (p < 0.05).CC BY · PubMed Central
Figure 6 The primary mass spectrogram and corresponding secondary mass spectrogram of FGMPLDR and MELVLR. (A) MS/MS spectra of FGMPLDR. (B) The secondary mass spectrogram of FGMPLDR. (C) MS/MS spectra of MELVLR. (D) The secondary mass spectrogram of MELVLR.
Figure 6 The primary mass spectrogram and corresponding secondary mass spectrogram of FGMPLDR and MELVLR. (A) MS/MS spectra of FGMPLDR. (B) The secondary mass spectrogram of FGMPLDR. (C) MS/MS spectra of MELVLR. (D) The secondary mass spectrogram of MELVLR.CC BY · PubMed Central
Figure 7 Molecular docking results for FGMPLDR and MELVLR with ACE (PDB: 1O8A). (A) 3-D details of ACE and FGMPLDR interactions. (B) 2-D interaction details for FGMPLDR. (C) 3-D details of ACE and MELVLR interactions. (D) 2D interaction details for MELVLR.
Figure 7 Molecular docking results for FGMPLDR and MELVLR with ACE (PDB: 1O8A). (A) 3-D details of ACE and FGMPLDR interactions. (B) 2-D interaction details for FGMPLDR. (C) 3-D details of ACE and MELVLR interactions. (D) 2D interaction details for MELVLR.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

Sorted by citations

See all 140

Metadata

Authors
Sun, S., Xu, X., Sun, X., Zhang, X., Chen, X., & Xu, N.
Affiliations
  • Ningbo University (CN)
  • Vanderbilt University Medical Center (US)
Corresponding author
Xu, Nianjun
Venue
Marine Drugs
Publisher
MDPI AG
Published
2019-03-19
Volume
17
Issue
3
Pages
179
ISSN
1660-3397 (ISSN-L)
OpenAlex
W2922600776
Cited by
140
References
50
Citations by year
2026: 9 · 2025: 21 · 2024: 29 · 2023: 22 · 2022: 27 · 2021: 15 · 2020: 14 · 2019: 3
FWCI
4.88
Type
journal article
Language
en
Open access
Locations
  • Marine Drugs (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Discover Archive (Vanderbilt University) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Natural Science Foundation of Zhejiang Province (LZ17D060001)
  • Ningbo International Cooperation Program (2017D10019)
  • Ningbo Municipal Bureau of Science and Technology (2016C10034)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Protein Hydrolysis and Bioactive Peptides
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
Keywords
ACE inhibitory peptides, Ulva intestinalis, seaweed, protein hydrolysates, trypsin hydrolysis, enzymatic hydrolysis optimization, peptide purification, antihypertensive peptides, food-derived bioactive peptides, zinc binding
MeSH terms
Angiotensin-Converting Enzyme Inhibitors, Antihypertensive Agents, Drug Stability, Hydrolysis, Hypertension, Peptidyl-Dipeptidase A, Peptide Hydrolases, Peptides, Protein Hydrolysates, Seaweed, Inhibitory Concentration 50, Ulva, Enzyme Assays, Molecular Docking Simulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review